跳至主要内容
临床试验/NCT00094081
NCT00094081已完成3 期

Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine Versus Concomitant Radiation and Cisplatin in Patients With Advanced Head and Neck Cancer

Sanofi10 个研究点 分布在 1 个国家目标入组 861 人开始时间: 2002年10月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Sanofi
入组人数
861
试验地点
10
主要终点
Overall survival.

研究概览

简要总结

The trial will compare the efficacy and safety of concomitant chemoradiation with tirapazamine, cisplatin and radiation versus cisplatin and radiation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Previously untreated squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx.
  • •Stage III or IV disease (excluding T1N1, and T2N1).
  • •ECOG performance status less than or equal to
  • •Absolute neutrophil count at least 1.5 X 10^9/L, platelet count at least 100 X 10^9/L, and hemoglobin > 9g/dL.
  • •Serum bilirubin < 1.25 times ULN and AST/ALT < 2.5 times ULN.
  • •Calculated creatinine clearance (Cockcroft-Gault) > 55 mL/min.

排除标准

  • •Metastatic Disease

结局指标

主要结局

Overall survival.

次要结局

  • Time to locoregional failure.

研究者

发起方
Sanofi
申办方类型
Industry

研究点 (10)

Loading locations...

相似试验

已完成
3 期
TRACE: Tirapazamine-Radiation And Cisplatin EvaluationHead and Neck Squamous Cell Carcinoma
NCT00174837Sanofi317
招募中
3 期
Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine CancerGemcitabineChemo-radiotherapyLocally Advanced Cervical Cancer
NCT06156514National Institute of Cancerología140
进行中(未招募)
3 期
Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal CancersCervical Squamous Cell CarcinomaAdvanced Vaginal AdenocarcinomaStage II Cervical Cancer AJCC v7Stage IIB Cervical Cancer AJCC v6 and v7Stage IVA Vaginal Cancer AJCC v6 and v7Unresectable Vaginal CarcinomaVaginal AdenocarcinomaCervical AdenocarcinomaStage IIIB Cervical Cancer AJCC v6 and v7Stage IVA Cervical Cancer AJCC v6 and v7Cervical Adenosquamous CarcinomaStage II Vaginal Cancer AJCC v6 and v7Stage IV Vaginal Cancer AJCC v6 and v7Vaginal CarcinomaAdvanced Vaginal Adenosquamous CarcinomaAdvanced Vaginal Squamous Cell CarcinomaStage IB2 Cervical Cancer AJCC v6 and v7Stage IIA Cervical Cancer AJCC v7Vaginal Squamous Cell Carcinoma, Not Otherwise SpecifiedStage III Vaginal Cancer AJCC v6 and v7Vaginal Adenosquamous Carcinoma
NCT02466971National Cancer Institute (NCI)450
终止
3 期
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical CancerCervical AdenocarcinomaCervical Adenosquamous Cell CarcinomaStage IB Cervical CancerStage IIA Cervical CancerStage IIB Cervical CancerStage III Cervical CancerStage IVA Cervical CancerCervical Squamous Cell Carcinoma
NCT00262821National Cancer Institute (NCI)402
已完成
2 期
Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck CancerSquamous Neck Carcinoma of the Head and Neck Cancer (SCCHN)
NCT00002774Stanford University63